MarketCapTrends
ASMB

Assembly Biosciences Inc. (ASMB)

NASDAQ · Healthcare

Assembly Biosciences Inc. annual/quarterly total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Assembly Biosciences Inc. total liabilities for the quarter ending December 31, 2025 were 50.8M, a 40.75% decrease year-over-year.
  • Assembly Biosciences Inc. total liabilities for 2025 were 50.8M, a 40.75% decrease from 2024.
  • Assembly Biosciences Inc. total liabilities for 2024 were 85.8M, a 10.36% decrease from 2023.
  • Assembly Biosciences Inc. total liabilities for 2023 were 95.7M, a 400.40% increase from 2022.
  • Assembly Biosciences Inc. total liabilities for 2022 were 19.1M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Assembly Biosciences Inc. Annual Total Liabilities (Millions of US $)
2025$51
2024$86
2023$96
2022$19
2021$22
2020$43
2019$67
2018$57
2017$56
2016$18
Assembly Biosciences Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$51
2024-12-31$86
2023-12-31$96
2022-12-31$19
2021-12-31$22
2020-12-31$43
2019-12-31$67
2018-12-31$57
2017-12-31$56
2016-12-31$18

Assembly Biosciences Inc. Total Liabilities — FAQ

Assembly Biosciences Inc. (ASMB) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ASMB's total liabilities history?

The chart and table above show Assembly Biosciences Inc.'s total liabilities by year and by quarter, including the growth rate.